SIERRA OLSON: Open Payments
NPI 1588244081 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 71 payments from 10 companies in 2025. Trend: 2023 $1,242 · 2024 $1,215 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $349 |
| Biogen, Inc. | 13 | $313 |
| Exeltis, USA Inc. | 18 | $206 |
| MILLICENT US INC | 19 | $191 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $112 |
| Astellas Pharma US Inc | 2 | $49 |
| Exact Sciences Corporation | 2 | $35 |
| COLOPLAST CORP | 1 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
Products named: ZURZUVAE, Ozempic, FEMLYV, TWIRLA, SLYND, INTRAROSA, Veozah, Wegovy.
Industry payments across TX — which companies pay providers there.
